OpenLobby.EU

Terumo Blood and Cell Technologies

Terumo BCT, a global leader in blood component and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading technologies in therapeutic apheresis and cell processing.

Lobbying Activity

Meeting with András Tivadar Kulja (Member of the European Parliament)

17 Dec 2024 · Sickle Cell Disease

Meeting with Stine Bosse (Member of the European Parliament)

18 Sept 2024 · Health Policy

Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament) and

18 Sept 2024 · Introductory Meeting

Meeting with Stelios Kympouropoulos (Member of the European Parliament)

6 Mar 2024 · sickle cell disease

Meeting with Josianne Cutajar (Member of the European Parliament)

4 Mar 2024 · Sickle Cell Disease

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

28 Feb 2024 · Rare diseases, Sickle Cell Disease

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

10 Nov 2022 · Blood, Tissues and Cells Regulation

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC

7 Sept 2022

Response to Revision of Directive 2002/98/EC on safety and quality of human blood and blood components and of Directive 2004/23/EC on safety and quality of human tissues and cells and their implementing acts.

14 Dec 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

7 Jul 2020

Response to Communication from the Commission on Improving Health Security in the EU – a one health approach to counteracting the threat from infectious diseases

23 Apr 2018